measl
viru
mv
morbilliviru
remain
signific
human
pathogen
infect
central
nervou
system
result
rare
often
fatal
diseas
subacut
scleros
panenceph
previou
work
demonstr
mv
transmit
transsynapt
cellular
receptor
hemagglutinin
h
protein
requir
mv
entri
dispens
subsequ
celltocel
spread
explor
role
envelop
protein
fusion
f
play
transsynapt
transport
made
follow
observ
mvf
express
infect
neuron
similar
seen
infect
fibroblast
fusion
inhibitori
peptid
fip
inhibitor
mv
fusion
prevent
infect
spread
primari
neuron
substanc
p
neurotransmitt
activ
site
fip
also
block
neuron
mv
spread
genet
delet
pharmacolog
inhibit
substanc
p
receptor
reduc
infect
suscept
mice
togeth
data
implic
role
mv
cn
infect
spread
perhap
serv
mvf
receptor
coreceptor
neuron
rare
case
mv
invad
persist
within
human
central
nervou
system
cn
lead
progress
fatal
neurolog
diseas
includ
subacut
scleros
panenceph
sspe
anlar
griffin
bellini
schneiderschauli
et
al
two
hallmark
sspe
protract
period
initi
infect
sign
diseas
often
year
inabl
recov
infecti
viru
affect
brain
tissu
despit
extens
presenc
mv
rna
protein
katz
payn
baubli
itabashi
contrast
rapid
highli
product
infect
occur
noncn
tissu
appar
differ
mv
replic
spread
within
human
present
address
rosetta
biosoftwar
terri
avenu
north
seattl
wa
b
present
address
case
western
reserv
univers
depart
molecular
biolog
microbiolog
euclid
avenu
cleveland
oh
c
correspond
author
fox
chase
cancer
center
cottman
avenu
philadelphia
pennsylvania
phone
email
glennral
fcccedu
cn
impli
viral
neurotransmiss
substant
less
cytopath
product
nonneuron
tissu
mice
normal
nonpermiss
mv
thu
studi
mv
spread
pathogenesi
cn
transgen
mous
model
neuron
infect
develop
transgen
mice
express
first
identifi
human
mv
receptor
dorig
et
al
nanich
et
al
thought
primari
receptor
vaccin
strain
cattaneo
transcript
control
neuronspecif
promot
neuronspecif
enolas
nse
rall
et
al
subsequ
challeng
transgen
mice
vaccin
strain
mvedmonston
either
intracerebr
intranas
rout
result
infect
transgen
mice
adult
immunocompet
mice
resolv
infect
neonat
immunodefici
eg
rag
knockout
ko
adult
develop
cn
diseas
result
unrestrict
neuron
infect
lawrenc
et
al
rall
et
al
use
primari
hippocamp
neuron
obtain
embryo
show
mv
neuron
infect
noncytopath
result
releas
extracellular
progeni
despit
extens
viral
spread
lawrenc
et
al
interestingli
neurontoneuron
spread
mv
occur
exclus
synaps
requir
express
lawrenc
et
al
oldston
et
al
rall
et
al
indic
hemagglutinin
h
receptor
interact
may
requir
synapt
interfac
lawrenc
et
al
base
observ
next
want
establish
role
viral
fusion
protein
play
transsynapt
transport
gener
believ
h
f
interact
domain
coordin
receptor
bind
fusion
hu
ray
compan
work
laboratori
suggest
f
may
act
independ
h
may
even
govern
target
cell
specif
exampl
simian
viru
f
promot
fusion
absenc
hemagglutininneuraminidas
hn
protein
albeit
less
effici
hn
present
horvath
et
al
ito
et
al
moreov
f
protein
mutant
requir
hn
fusion
fuse
hnindepend
manner
higher
temperatur
thu
fusion
may
requir
surmount
thermodynam
threshold
accomplish
conform
chang
hn
protein
increas
temperatur
perhap
interact
f
protein
cellular
receptor
dutch
et
al
paterson
russel
lamb
final
possibl
support
literatur
sinc
f
fusion
protein
respiratori
syncyti
viru
rsv
pneumoviru
within
paramyxoviru
famili
determin
host
cell
tropism
schendler
et
al
recombin
rsv
particl
lack
g
protein
remain
viabl
abl
spread
techaarpornkul
barretto
peepl
studi
inhibitor
paramyxoviru
fusion
fusion
inhibitori
peptid
fip
use
richardson
choppin
richardson
scheid
choppin
tripeptid
sequenc
fip
phephegli
ident
activ
site
neurotransmitt
substanc
p
figur
also
inhibit
mv
spread
nonneuron
cultur
harrow
mitsuhashi
payan
schroeder
substanc
p
transduc
signal
target
cell
engag
neurotachykinin
famili
g
proteincoupl
neurotransmitt
receptor
includ
gerard
et
al
schaffer
et
al
highli
conserv
protein
express
divers
mammalian
cell
includ
neuron
lymphocyt
smooth
muscl
cell
vascular
endothelium
pennefath
et
al
express
ubiquit
within
cn
though
central
structur
display
express
mantyh
neuron
broadli
distribut
plasma
membran
though
concentr
synaps
bozic
et
al
show
fip
substanc
p
prevent
mv
spread
neuron
genet
delet
pharmacolog
inhibit
also
reduc
infect
permiss
mice
togeth
data
indic
fusion
requir
step
viral
transport
across
synapt
cleft
suggest
play
key
role
process
perhap
serv
mvf
receptor
previous
show
interneuron
transmiss
mv
transsynapt
lawrenc
et
al
neuron
nonpermiss
infect
extracellular
viru
could
support
infect
cocultur
infect
neuron
hypothes
mvh
protein
though
need
initi
mv
entri
may
dispens
neurontoneuron
transsynapt
spread
mv
mvh
f
typic
involv
viral
entri
spread
next
ask
whether
mvf
translat
process
infect
neuron
lysat
prepar
mvinfect
mockinfect
neuron
vero
cell
western
blot
use
rabbit
antibodi
rais
f
carboxi
terminu
cathomen
naim
cattaneo
perform
protein
lysat
equival
infect
cell
mockinfect
control
amount
lysat
correspond
cell
use
mvf
synthes
precursor
f
posttransl
cleav
two
subunit
f
f
shown
figur
equival
number
infect
vero
fibroblast
neuron
yield
f
f
fragment
though
amount
present
neuron
consist
less
despit
slight
differ
express
level
cleavag
f
protein
effici
cell
type
note
f
fragment
recogn
antibodi
fusion
inhibitori
peptid
fip
synthet
tripeptid
zdphelphegli
prevent
fusion
multipl
virus
though
strongest
activ
mv
norrbi
richardson
choppin
richardson
scheid
choppin
determin
fip
block
mv
spread
neuron
primari
neuron
obtain
embryon
hippocampi
control
vero
fibroblast
infect
mved
use
rang
moi
follow
addit
fip
hr
postinfect
hpi
cell
collect
dpi
immunostain
presenc
mv
antigen
one
repres
experi
three
use
fip
shown
figur
vero
cell
without
fip
mv
spread
rapidli
result
extens
infect
syncytia
figur
expect
addit
fip
infect
prevent
viral
spread
syncytia
format
monolay
remain
intact
figur
fip
ad
hpi
individu
mvposit
cell
expect
similarli
addit
fip
primari
infect
block
transsynapt
neuron
transmiss
mv
figur
otherwis
observ
untreat
cultur
figur
ident
result
obtain
infect
fip
addit
separ
hr
moi
use
data
shown
shown
tabl
effect
fip
addit
mv
spread
dosedepend
cell
type
inhibit
occur
inhibitori
effect
fip
specif
mv
ident
experi
two
neurotrop
rna
virus
lymphocyt
choriomening
viru
lcmv
polioviru
pv
show
differ
infect
level
presenc
fip
data
shown
initi
character
paramyxoviru
hydrophob
fusion
inhibitor
show
de
novo
infect
subsequ
celltocel
spread
prevent
norrbi
richardson
choppin
richardson
scheid
choppin
hand
howev
addit
fip
prior
viral
challeng
prevent
infect
vero
cell
figur
though
subsequ
viral
spread
block
figur
f
suppress
effect
fip
revers
fip
wash
cultur
dpi
mv
rebound
rapidli
result
cytopath
syncytia
format
observ
untreat
cultur
compar
figur
contrast
pretreat
neuron
fip
complet
block
infect
figur
expect
fip
washout
result
mv
reemerg
figur
inabl
fip
block
infect
vero
could
due
cellspecif
differ
receptor
densiti
distribut
util
put
fusion
receptor
discuss
access
fip
cell
surfac
taken
togeth
data
indic
fip
prevent
infect
spread
primari
mous
hippocamp
neuron
phexgli
sequenc
fip
also
activ
site
neurotachykinin
famili
peptid
neurotransmitt
includ
substanc
p
neurokinin
neurokinin
b
figur
substanc
p
central
residu
motif
phenylalanin
fip
neurokinin
b
valin
addit
fip
central
phe
residu
lisom
wherea
neurokinin
disom
previous
shown
substanc
p
could
inhibit
mv
spread
nonneuron
cultur
harrow
mitsuhashi
payan
schroeder
determin
neurotachykinin
block
mv
transneuron
spread
model
system
perform
inhibit
experi
ident
describ
fip
use
three
neurotachykinin
two
nonneurotachykinin
peptid
transmitt
bradykinin
opioid
receptor
antagonist
peptid
substanc
p
antagonist
spantid
contain
phexgli
motif
peptid
ad
indic
concentr
hpi
cell
collect
dpi
immunostain
mv
number
infect
cell
express
rel
dmso
treat
cultur
normal
one
repres
experi
five
shown
figur
note
figur
neuropeptid
ad
infect
infect
cell
expect
cultur
infect
baselin
dpi
indic
solid
line
approxim
studi
viru
yield
use
measur
activ
extracellular
viru
releas
infect
primari
neuron
lawrenc
et
al
member
neurotachykinin
famili
inhibit
mv
transmiss
dosedepend
manner
although
substanc
p
show
greater
potenc
nka
nkb
concentr
figur
data
shown
nonneurotachykinin
peptid
effect
mv
transmiss
moreov
spantid
substanc
p
antagonist
lack
phephegli
motif
presum
bind
site
substanc
p
also
effect
mv
spread
underscor
potenti
import
motif
mvmediat
fusion
next
ask
cellular
receptor
neurotachykinin
peptid
requir
mv
spread
particular
emphasi
predomin
substanc
p
receptor
two
strategi
use
genet
knockout
mice
figur
pharmacolog
inhibitor
figur
knockout
ko
mice
bozic
et
al
intercross
homozyg
mice
obtain
ko
mice
report
origin
character
ko
mice
show
appar
development
abnorm
regard
lifespan
fertil
fecund
brain
anatomi
bozic
et
al
mice
genotyp
statu
describ
materi
method
neonat
mice
also
succumb
mvmediat
cn
diseas
follow
viral
challeng
lawrenc
et
al
rall
et
al
ask
impact
genet
delet
would
mv
neuron
infect
result
pathogenesi
neonat
model
previous
shown
mvinfect
control
neonat
black
triangl
develop
symptom
within
dpi
die
day
thereaft
figur
contrast
ko
neonat
black
circl
either
show
sign
ill
adulthood
develop
ill
much
later
time
dpi
ko
neonat
vs
dpi
neonat
figur
none
surviv
ko
mice
show
evid
mv
cn
infect
rtpcr
analysi
contrast
mv
antigen
observ
moribund
ko
mice
collect
dpi
data
shown
expect
mice
white
circl
nonpermiss
infect
show
sign
ill
infect
timepoint
indic
alon
mediat
mv
entri
ascertain
extent
mv
infect
express
nonexpress
neonat
collect
timepoint
postinfect
neonat
ko
mice
challeng
describ
brain
mice
collect
dpi
approxim
peak
infect
within
cn
lawrenc
et
al
detect
mvn
gene
rtpcr
analysi
total
brain
rna
show
evid
replic
mice
wherea
ko
mice
posit
figur
data
suggest
even
present
express
requir
infect
major
mice
howev
influenc
number
mice
infect
kinet
infect
obligatori
ko
neonat
suscept
infect
neuropathogenesi
altern
strategi
ascertain
role
play
mv
infect
neuron
highaffin
pharmacolog
antagonist
aprepit
current
use
clinic
antiemet
emend
employ
unlik
genet
knockout
studi
describ
neonat
could
use
aprepit
studi
technic
obstacl
oral
drug
deliveri
neonat
mice
thu
adult
mice
ko
background
use
mice
lack
matur
b
cell
resolv
mv
challeng
virtual
becom
moribund
dpi
lawrenc
et
al
shown
figur
mvinocul
ko
mice
receiv
aprepit
show
averag
weight
loss
averag
ill
score
obtain
day
prior
sacrific
contrast
aprepitanttr
ko
mice
segreg
two
popul
develop
neuropatholog
repres
experi
shown
mice
develop
milder
ill
nonaprepit
treat
control
vs
weight
loss
mice
less
averag
importantli
mvchalleng
mice
treat
aprepit
show
sign
ill
weight
loss
rtpcr
analysi
purifi
total
brain
rna
confirm
absenc
mvn
rna
brain
healthi
aprepitanttr
mice
data
shown
brain
collect
aprepitanttr
untreat
mvinfect
ko
mice
dpi
immunostain
mice
without
aprepit
show
characterist
extens
unrestrict
infect
cn
figur
ac
wherea
sick
mice
treat
aprepit
less
viral
infect
seem
focal
restrict
within
parenchyma
figur
df
evid
mv
infect
within
cn
observ
healthi
mice
receiv
aprepit
figur
gi
taken
togeth
result
drug
knockout
experi
indic
receptor
neurotransmitt
substanc
p
play
crucial
role
mv
spread
hypothes
may
dock
receptor
mvf
protein
facilit
celltocel
mv
transmiss
previou
studi
demonstr
mechan
mv
transmiss
neuron
differ
dramat
nonneuron
cell
lawrenc
et
al
fibroblast
mv
highli
cytolyt
result
robust
releas
infecti
particl
contrast
virusmedi
lysi
infect
primari
hippocamp
neuron
detect
could
extracellular
viru
recov
despit
extens
viral
replic
spread
electron
microscopi
studi
reveal
block
abil
mv
bud
neuron
plasma
membran
well
presenc
viral
rnp
synapt
junction
indic
mv
adopt
transsynapt
mode
spread
neuron
lawrenc
et
al
interestingli
transsynapt
transmiss
characterist
appear
uniqu
neuron
requir
viral
spread
fibroblast
cocultur
makhortova
et
al
manuscript
press
synthet
tripeptid
fip
block
mv
fusion
norrbi
payan
et
al
richardson
choppin
inhibit
mv
infect
spread
primari
neuron
express
one
human
receptor
mechan
fip
prevent
fusion
known
may
either
due
direct
interfer
amino
terminu
subunit
target
cell
membran
prevent
exposur
fusogen
peptid
norrbi
richardson
choppin
kelsey
similar
sequenc
fip
neurotransmitt
substanc
p
coupl
previou
report
substanc
p
could
interfer
mv
replic
nonneuron
cell
schroeder
richardson
scheid
choppin
prompt
us
ask
whether
substanc
p
member
neurotachykinin
famili
could
prevent
viral
transloc
across
synapt
cleft
inde
neurotachykinin
block
spread
process
appear
depend
least
part
presenc
neurotachykinin
receptor
major
defici
neonat
well
adult
mice
treat
specif
antagonist
aprepit
surviv
viral
challeng
without
symptom
diseas
viral
replic
cn
thu
specul
may
promot
mv
entri
neuron
serv
dock
receptor
mvf
protein
abil
fip
substanc
p
block
infect
spread
may
due
competit
inhibit
receptor
hypothesi
current
studi
laboratori
appar
abil
mediat
viral
spread
neuron
synaps
absenc
h
receptor
may
uniqu
attribut
special
membran
mved
transsynapt
spread
occur
absenc
primari
mous
neuron
express
identifi
mv
receptor
data
indic
transsynapt
spread
may
requir
receptor
h
protein
rule
possibl
protein
express
postsynapt
membran
may
serv
uniqu
hreceptor
neuron
specif
facilit
neurontoneuron
transport
across
synaps
howev
given
similar
sequenc
activ
substanc
p
fusion
inhibitor
fip
favor
idea
f
bind
neurokinin
receptor
facilit
transport
mv
rnp
across
synaps
absenc
need
h
importantli
express
mammal
virtual
cell
includ
vero
fibroblast
use
control
experi
data
shown
thu
also
current
test
whether
necessari
cofactor
mv
entri
permiss
cell
moreov
given
studi
perform
mvedmonston
vaccin
strain
import
address
role
play
entri
spread
wild
type
isol
data
implic
import
role
mv
spread
neuron
infect
mice
delet
impair
becom
infect
neither
fip
substanc
p
abl
fulli
ablat
mv
spread
primari
neuron
inabl
could
explain
insuffici
concentr
inhibitor
synapt
membran
b
rapid
offrat
substanc
p
sarntinoranont
iadarola
morrison
andor
c
potenti
mvf
util
multipl
neurokinin
receptor
includ
entri
three
neurotachykinin
inhibit
mv
spread
degre
figur
serv
ligand
three
differ
neurokinin
receptor
remain
possibl
neurokinin
receptor
may
serv
surrog
mv
entri
circumst
present
activ
recent
paper
provid
addit
support
fusiontachykinin
relationship
f
protein
bovin
respiratori
syncyti
viru
brsv
member
paramyxoviru
famili
posttransl
cleav
twice
unlik
mvf
cleav
small
peptid
releas
brsvf
cleavag
convert
biolog
activ
tachykinin
call
virokinin
solubl
virusencod
peptid
interact
trigger
downstream
pathway
bona
fide
ligand
substanc
p
thu
fusion
protein
posttransl
cleav
product
deriv
fusion
protein
multipl
paramyxovirus
appear
interact
neurokinin
receptor
though
benefit
interact
confer
viru
yet
understood
final
data
may
implic
mv
pathogenesi
cn
mous
model
neuron
mv
infect
cn
diseas
occur
infect
immunodefici
anim
absenc
neuron
death
patterson
et
al
suggest
cn
diseas
mous
model
due
neuron
dysfunct
rather
overt
cell
loss
hypothes
mvmediat
fusion
neuron
synaps
could
promot
neuropatholog
number
possibl
mechan
includ
constitut
neurotransmitt
signal
loss
synapt
integr
continu
use
model
system
allow
us
determin
receptor
interact
may
contribut
neuropatholog
may
identifi
novel
candid
antivir
therapi
prevent
limit
mvinduc
neuropatholog
human
vero
fibroblast
maintain
dulbecco
modifi
eagl
medium
dmem
life
technolog
supplement
fetal
calf
serum
fc
mm
glutamin
uml
penicillin
ngml
streptomycin
primari
hippocamp
neuron
prepar
day
embryon
mice
describ
banker
goslin
pasick
kalicharran
dale
rall
muck
oldston
except
cell
maintain
neurobas
medium
life
technolog
contain
glutam
absenc
astrocyt
feeder
layer
neuron
obtain
embryon
brain
tissu
except
control
polioviru
studi
neuron
isol
pvr
transgen
mice
gift
raul
andino
ucsf
cell
maintain
humidifi
incub
co
measl
viru
mv
edmonston
strain
purchas
american
type
cell
collect
atcc
passag
titer
vero
fibroblast
polioviru
pv
mahoney
strain
gift
lui
sigal
fox
chase
cancer
center
lymphocyt
choriomening
viru
lcmv
armstrong
strain
gift
michael
oldston
scripp
research
institut
la
jolla
ca
passag
fibroblast
titer
vero
fibroblast
hippocamp
neuron
plate
onto
polylysin
coat
tissu
cultur
dish
infect
hr
postplat
mved
multipl
infect
moi
vero
fibroblast
hr
postplat
infect
ident
three
day
later
infect
mockinfect
cell
lysat
collect
scrape
cell
protein
buffer
follow
sec
sonic
sampl
store
boil
min
prior
load
protein
separ
use
sdspage
transfer
nylon
membran
rabbit
polyclon
antiserum
direct
mvf
cytoplasm
tail
gift
roberto
cattaneo
mayo
clinic
rochest
mn
cathomen
naim
cattaneo
use
primari
antibodi
dilut
milk
follow
incub
peroxidaseconjug
antirabbit
igg
secondari
antibodi
dilut
vector
laboratori
band
visual
use
chemiluminesc
ecl
dupont
nen
coverslipbound
cell
cryosect
micronthick
horizont
brain
section
fix
icecold
methanolaceton
min
dri
rehydr
pb
sampl
block
volvol
normal
goat
serum
pb
follow
avidin
biotin
block
vector
laboratori
human
antiserum
keller
gift
michael
oldston
use
dilut
appropri
secondari
antibodi
conjug
biotin
use
dilut
streptavidinperoxidas
conjug
abc
elit
vector
ad
follow
visual
diaminobenziden
dab
mgml
mm
tri
sigma
h
mgml
cell
section
counterstain
hematoxylin
mount
aqueou
mount
medium
control
uninfect
cell
brain
sampl
primari
antibodi
omit
sampl
use
irrelev
isotypematch
primari
antibodi
includ
determin
impact
variou
reagent
viral
infect
primari
neuron
control
vero
cell
first
treat
reagent
indic
concentr
hr
follow
infect
presenc
put
inhibitor
follow
hr
incub
viru
inoculum
remov
cell
gentli
wash
warm
pb
ph
thereaft
appropri
medium
contain
fresh
inhibitor
ad
coverslip
fix
indic
day
postinfect
dpi
explor
impact
reagent
viral
spread
process
revers
cell
infect
either
hr
follow
addit
reagent
thereaft
indic
concentr
reagent
obtain
bachem
dissolv
dmso
acet
acid
reagent
use
includ
follow
fusion
inhibitori
peptid
fip
zdphelpheglyoh
neurotachykinin
substanc
p
hargprolysproglnglnphepheglyleumetnh
neurokinin
hhislysthraspserphevalglyleumetnh
neurokinin
b
haspmethisaspphephevalglyleumetnh
bradykinin
hargproproglypheserpropheargoh
opioid
receptor
antagonist
htyrticnh
substanc
p
antagonist
spantid
hdargprolysproglnglndtrpphedtrpleuleunh
control
cultur
incub
equival
volum
dmso
acet
acid
coverslip
harvest
stain
mv
indic
adult
mice
week
age
neonat
mice
day
age
use
knockout
ko
mice
b
obtain
norma
gerard
harvard
univers
bozic
et
al
intercross
gener
transgen
mice
b
mice
genotyp
verif
haplotyp
perform
dna
isol
tail
biopsi
blood
sampl
collect
retroorbit
sinu
confirm
statu
standard
pcr
cycl
perform
use
follow
primer
upstream
cggtc
gctac
catta
ccagt
downstream
ccccc
tgaac
ctgaa
acata
confirm
ko
statu
two
primer
pair
use
one
pair
verifi
absenc
target
region
gene
upstream
ttgag
tcctg
ctact
cagga
downstream
acttt
tacta
gctgc
gctgc
confirm
presenc
neomycin
resist
gene
upstream
tcagc
gcagg
ggcgc
ccggt
tcttt
downstream
atcga
caaga
ccggc
ttcca
tccga
neonat
ko
mice
less
day
age
challeng
intracerebr
pfu
mved
deliv
volum
l
along
midlin
use
gaug
needl
infect
pup
monitor
daili
anim
show
sign
virusinduc
ill
matern
reject
absenc
weight
gain
euthan
aprepit
emend
merck
pharmaceut
studi
adult
mice
dose
recommend
human
mgkg
adjust
bodi
weight
given
adult
mice
ko
background
lawrenc
et
al
drug
suspend
pb
deliv
volum
l
via
oral
gavag
everi
day
follow
viral
challeng
day
prior
infect
doubl
dose
drug
administ
anim
health
monitor
daili
mice
weigh
assess
everi
day
follow
viral
challeng
health
assess
mice
score
base
follow
subject
scale
ruffl
hunch
lack
mobil
two
symptom
sever
appear
one
three
symptom
sever
incid
two
mous
experi
review
approv
fox
chase
cancer
center
iacuc
mice
brain
tissu
collect
either
ihc
rna
analysi
ihc
studi
tissu
immers
oct
embed
compound
quickfrozen
dri
iceisopentan
bath
store
thereaft
micron
cryosect
obtain
store
section
thaw
fix
icecold
ethanol
immunostain
describ
isol
rna
infect
tissu
brain
snapfrozen
liquid
nitrogen
homogen
trireag
sigma
thereaft
rna
purifi
qualitytest
gel
electrophoresi
rna
subject
rtpcr
use
superscript
ii
revers
transcriptas
invitrogen
follow
amplif
use
mvspecif
primer
nucleoprotein
upstream
actta
ggagc
aaagt
gattg
cct
downstream
aacaa
cacgg
aacct
ctgcg
g
amplicon
visual
electrophoresi
agaros
gel
hpi
mved
primari
neuron
vero
cell
fix
immunostain
solubil
protein
sampl
buffer
describ
percent
infect
cell
determin
immunochemistri
protein
lysat
volum
equival
infect
cell
subject
western
blot
analysi
use
antif
antibodi
size
standard
indic
right
shown
one
repres
experi
three
surviv
curv
follow
mv
challeng
neonat
black
triangl
neonat
white
circl
ko
neonat
black
circl
shown
one
repres
experi
three
neonat
chosen
mice
permiss
mv
infect
develop
cn
diseas
within
week
postchalleng
lawrenc
et
al
b
rtpcr
analysi
mvnucleoprotein
total
brain
rna
harvest
neonat
ko
mice
dpi
mved
describ
materi
method
mice
infect
describ
administ
aprepit
oral
one
day
prior
infect
doubl
dose
one
day
infect
everi
day
thereaft
mice
monitor
daili
score
base
defin
criteria
see
materi
method
averag
valu
obtain
day
shown
mice
also
weigh
day
infect
establish
individu
baselin
everi
day
thereaft
maxim
weight
chang
shown
percent
weight
loss
gain
b
mice
infect
describ
collect
day
postinfect
shown
immunohistochem
result
untreat
ac
aprepitanttr
di
mice
df
sick
anim
collect
gi
healthi
anim
collect
origin
